Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C

Hepatology

Volumn 28, Issue 1, 1998, Pages 225-230

  Nelson, David R ^a   Marousis, Constantine G ^a   Ohno, Tomoyoshi ^a   Davis, Gary L ^a   Lau, Johnson Y N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD8 ANTIGEN; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; HLA ANTIGEN; RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DEPRESSION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME;

EID: 0031808407     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280129     Document Type: Article

References (8)

1. Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, et al. T and B cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and healthy anti-HCV seropositives. HEPATOLOGY 1996;24:790-795.
2. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest 1996;98:706-714.
3. Cemy AJ, Mchutchinson JG, Pasquinelli C, Brown ME, Brothers MA, Grabsheid B, Fowler P, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995;95:521-530.
4. Koziel MJ, Dudley D, Wong JT, Dienstag J, Houghton M, Ralston R, Walker BD. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992;149:3339-3344.
5. Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD. Hepatitis C virus-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993;67:7522-7528.
6. Battegay M, Fikes J, Di Bisceglia AM, Wentworth PA, Sette A, Celis E, Ching WM, et al. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus encoded peptides binding to HLA-A2.1 molecules. J Virol 1995;69:2462-2470.
7. Nelson DR, Marousis CG, Davis GL, Rice CM, Wong J, Houghton M, Lau JYN. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997;158:1473-1481.
8. Byrne JA, Oldstone MBA. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis: clearance of virus in vivo. J Virol 1984;51:682-686.